title: Type 1 leprosy reaction manifesting after discontinuation of adalimumab therapy.
authors.forename: Ivan D
authors.initials: ID
authors.lastname: Camacho
authors.forename: Isabel
authors.initials: I
authors.lastname: Valencia
authors.forename: Maria P
authors.initials: MP
authors.lastname: Rivas
authors.forename: Anne E
authors.initials: AE
authors.lastname: Burdick
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D006801:Humans; D015439:Leprosy, Borderline / Q000175:diagnosis* / Q000473:pathology; D008297:Male; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab